Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notified
For the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also a part of the NLEM.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Bedaquiline | Biotechnology | Diabetes | Endocrinology | Hepatitis | Hepatitis C | Pharmaceuticals